| product Name |
2,3-dimethylindazol-6-amine hydrochloride |
| Synonyms |
2,3-dimethyl-2H-indazol-6-amine hydrochloride; 2,3-dimethyl-2H-indazol-6-amine HCl; 6-Amino-2,3-dimethyl-2H-indazole hydrochloride; 2,3-Dimethyl-2H-indazol-6-amine monohydrochloride; 2,3-Dimethyl-6-amino-2H-indazole hydrochloride |
| Molecular Formula |
C9H12ClN3 |
| Molecular Weight |
197.6647 |
| InChI |
InChI=1/C9H11N3.ClH/c1-6-8-4-3-7(10)5-9(8)11-12(6)2;/h3-5H,10H2,1-2H3;1H |
| CAS Registry Number |
635702-60-2 |
| Molecular Structure |
|
| Description |
2,3-dimethyl-2H-indazol-6-amine hydrochloride is a pharmaceutical intermediate impurity, a by-product from the preparation of pazopanib hydrochloride, which can be used as an impurity standard solution for experimental analysis. |
| Chemical Properties |
Powder |
| Uses |
2,3-Dimethyl-6-amino-2H-indazole is an impurity in the synthesis of Pazopanib (P210925) hydrochloride, an oral angiogenesis inhibitor targeting VEGFR and PDGFR. |
Reviews
There are no reviews yet.